Evidence map›Paper›PMID 35662347›Full record

ArticleCancer science2022

Dietary advanced glycation end products and cancer risk in Japan: From the Takayama study.

Keiko Wada, Yuma Nakashima, Michiyo Yamakawa, Akihiro Hori, Mitsuru Seishima, Shinobu Tanabashi, Shogen Matsushita, Naoki Tokimitsu, Chisato Nagata

Open access · goldAbstract read
In one paragraph

Article in Cancer science, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Toxic AGEs (TAGE) Cause Lifestyle-Related Diseases.Antioxidants (Basel, Switzerland) · 2024
    Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Keiko WadaDepartment of Epidemiology and Preventive Medicine, Gifu University Graduate School of Medicine, Gifu, Japan.ORCID https://orcid.org/0000-0002-5467-8592
Yuma NakashimaDepartment of Epidemiology and Preventive Medicine, Gifu University Graduate School of Medicine, Gifu, Japan.
Michiyo YamakawaDepartment of Epidemiology and Preventive Medicine, Gifu University Graduate School of Medicine, Gifu, Japan.
Akihiro HoriKumiai Kosei Hospital, Gifu, Japan.
Mitsuru SeishimaDepartment of Internal Medicine, Takayama Red Cross Hospital, Gifu, Japan.
Shinobu TanabashiDepartment of Internal Medicine, Takayama Red Cross Hospital, Gifu, Japan.
Shogen MatsushitaDepartment of Radiology, Takayama Red Cross Hospital, Gifu, Japan.
Naoki TokimitsuDepartment of Internal Medicine, Takayama Red Cross Hospital, Gifu, Japan.
Chisato NagataDepartment of Epidemiology and Preventive Medicine, Gifu University Graduate School of Medicine, Gifu, Japan.
Gifu University · JPTakayama Red Cross Hospital · JPGifu University Hospital · JP

Funding

the Ministry of Education, Culture, Sports, Science, and Technology of Japan 15 K15222
6 · The paper itself

Abstract

Few large epidemiological studies have evaluated the association between dietary advanced glycation end products (AGEs) and cancer risk. We evaluated the relationship between dietary AGE intake and the incidence of total cancer and site-specific cancers in a population-based prospective study in Japan. Participants were 14,173 men and 16,549 women who were 35 years of age or older in 1992. Dietary intake was assessed via a validated food frequency questionnaire. Intake of the AGE N

Indexed as

Glycation End Products, AdvancedLiver NeoplasmsDietFemaleHumansJapanMaleProspective StudiesRiskGlycation End Products, AdvancedAGEscancercohort studiesdietepidemiology

Identifiers

PMID35662347
PMCPMC9357612
OpenAlexW4281761105

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.